(ACRS) Aclaris Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Aclaris Therapeutics | (ACRS) share price targets
Complete technical analysis of Aclaris Therapeutics (ACRS) by charts plus indicators, forecast predictions and share price targets for Aclaris Therapeutics (ACRS)
Aclaris Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Aclaris Therapeutics is 1973940
| Date | Daily Closing Price | Open | High | Low | Volume |
| 03 Thu Jul 2025 | 1.44 | 1.46 | 1.49 | 1.44 | 0.204 times |
| 02 Wed Jul 2025 | 1.45 | 1.43 | 1.52 | 1.39 | 0.371 times |
| 01 Tue Jul 2025 | 1.41 | 1.44 | 1.47 | 1.38 | 0.362 times |
| 30 Mon Jun 2025 | 1.42 | 1.45 | 1.47 | 1.39 | 0.501 times |
| 27 Fri Jun 2025 | 1.47 | 1.63 | 1.63 | 1.41 | 5.854 times |
| 26 Thu Jun 2025 | 1.56 | 1.65 | 1.65 | 1.55 | 0.503 times |
| 25 Wed Jun 2025 | 1.63 | 1.56 | 1.63 | 1.54 | 0.492 times |
| 24 Tue Jun 2025 | 1.52 | 1.42 | 1.52 | 1.39 | 0.345 times |
| 23 Mon Jun 2025 | 1.39 | 1.46 | 1.46 | 1.34 | 0.747 times |
| 20 Fri Jun 2025 | 1.45 | 1.42 | 1.45 | 1.40 | 0.449 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 1.4 as stoploss in an intra day buy trade for a target of 1.49. However, stock will show a bearish move below 1.4.
Share price targets for Aclaris Therapeutics (ACRS)
| Target Type | Value |
| Downside Target | 1.05 |
| Downside Target | 1.16 |
| Downside Target | 1.34 |
| Downside Target | 1.37 |
| Downside Target | 1.42 |
| Upside Target | 1.45 |
| Upside Target | 1.52 |
| Upside Target | 1.56 |
| Upside Target | 1.59 |
| Upside Target | 1.65 |
| Upside Target | 2.09 |
Intraday share price targets for Aclaris Therapeutics (ACRS)
| Target Type | Value |
| Downside Intraday Target | 1.37 |
| Downside Intraday Target | 1.31 |
| Upside Intraday Target | 1.51 |
| Upside Intraday Target | 1.59 |
| Upside Intraday Target | 1.45 |
Weekly technical analysis of Aclaris Therapeutics (ACRS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 03 Thu Jul 2025 | 1.44 | 1.45 | 1.52 | 1.38 | 0.181 times |
| 27 Fri Jun 2025 | 1.47 | 1.46 | 1.65 | 1.34 | 7.298 times |
| 20 Fri Jun 2025 | 1.45 | 1.43 | 1.49 | 1.37 | 0.761 times |
| 13 Fri Jun 2025 | 1.47 | 1.55 | 1.59 | 1.45 | 0.683 times |
| 06 Fri Jun 2025 | 1.53 | 1.47 | 1.65 | 1.42 | 0.825 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Aclaris Therapeutics (ACRS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 03 Thu Jul 2025 | 1.44 | 1.44 | 1.52 | 1.38 | 0.072 times |
| 30 Mon Jun 2025 | 1.42 | 1.47 | 1.65 | 1.34 | 1.782 times |
| 30 Fri May 2025 | 1.46 | 1.38 | 1.56 | 1.16 | 0.809 times |
| 30 Wed Apr 2025 | 1.38 | 1.52 | 1.59 | 1.05 | 0.831 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Aclaris Therapeutics (ACRS)
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Aclaris Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Aclaris Therapeutics in short term but the sell signal is initial and weak.
Aclaris Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Aclaris Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Aclaris Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.47 and Aclaris Therapeutics (ACRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aclaris Therapeutics (ACRS) stock. Volume based technical analysis of Aclaris Therapeutics (ACRS) stock is negative.
Aclaris Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Aclaris Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Aclaris Therapeutics in short term but the sell signal is initial and weak.
Aclaris Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Aclaris Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Aclaris Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.47 and Aclaris Therapeutics (ACRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aclaris Therapeutics (ACRS) stock. Volume based technical analysis of Aclaris Therapeutics (ACRS) stock is negative.
Aclaris Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.